PRICE T ROWE ASSOCIATES INC /MD/ - EXELIXIS INC ownership

EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 339 filers reported holding EXELIXIS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of EXELIXIS INC
ValueSharesWeighting
Q3 2023$97,733
+3.3%
4,472,824
-9.6%
0.01%
+7.7%
Q2 2023$94,573
-19.0%
4,948,814
-17.7%
0.01%
-23.5%
Q1 2023$116,710
+9.8%
6,012,788
-9.3%
0.02%0.0%
Q4 2022$106,312
-99.9%
6,627,890
-17.4%
0.02%
-19.0%
Q3 2022$125,802,000
-55.0%
8,023,042
-40.2%
0.02%
-40.0%
Q2 2022$279,509,000
-21.8%
13,425,015
-14.9%
0.04%
-2.8%
Q1 2022$357,592,000
+14.4%
15,773,785
-7.8%
0.04%
+28.6%
Q4 2021$312,587,000
-14.2%
17,099,967
-0.8%
0.03%
-17.6%
Q3 2021$364,393,000
+1.6%
17,237,135
-12.4%
0.03%
+3.0%
Q2 2021$358,488,000
-23.5%
19,675,540
-5.1%
0.03%
-29.8%
Q1 2021$468,389,000
+32.7%
20,734,338
+17.9%
0.05%
+30.6%
Q4 2020$353,001,000
+5.8%
17,588,494
+28.9%
0.04%
-7.7%
Q3 2020$333,529,000
+4.3%
13,641,269
+1.3%
0.04%
-2.5%
Q2 2020$319,639,000
+67.3%
13,464,133
+21.4%
0.04%
+33.3%
Q1 2020$191,032,000
+68.7%
11,093,611
+72.6%
0.03%
+100.0%
Q4 2019$113,244,000
-0.6%
6,426,991
-0.3%
0.02%
-6.2%
Q3 2019$113,984,000
-13.2%
6,445,254
+4.9%
0.02%
-11.1%
Q2 2019$131,279,000
+8.3%
6,143,165
+20.7%
0.02%0.0%
Q1 2019$121,170,000
+103.3%
5,091,189
+68.0%
0.02%
+80.0%
Q4 2018$59,596,000
-2.0%
3,029,801
-11.7%
0.01%
+11.1%
Q3 2018$60,804,000
-41.5%
3,431,376
-29.0%
0.01%
-43.8%
Q2 2018$104,017,000
-53.5%
4,833,478
-52.1%
0.02%
-55.6%
Q1 2018$223,689,000
-18.1%
10,098,845
+12.5%
0.04%
-18.2%
Q4 2017$272,963,000
+20.9%
8,979,035
-3.6%
0.04%
+12.8%
Q3 2017$225,701,000
+8.8%
9,314,952
+10.6%
0.04%
+5.4%
Q2 2017$207,352,000
-6.2%
8,418,663
-17.4%
0.04%
-9.8%
Q1 2017$220,975,000
+34.4%
10,197,283
-7.5%
0.04%
+24.2%
Q4 2016$164,397,000
+1.5%
11,025,932
-12.9%
0.03%0.0%
Q3 2016$161,954,000
+33.6%
12,662,570
-18.4%
0.03%
+26.9%
Q2 2016$121,265,000
+21.4%
15,526,930
-37.8%
0.03%
+23.8%
Q1 2016$99,858,000
-29.3%
24,964,590
-0.3%
0.02%
-30.0%
Q4 2015$141,215,000
+2.3%
25,038,170
+1.8%
0.03%
-3.2%
Q3 2015$138,045,000
+121.7%
24,606,910
+48.6%
0.03%
+138.5%
Q2 2015$62,268,000
+36.8%
16,560,640
-6.5%
0.01%
+44.4%
Q1 2015$45,514,000
+70.3%
17,709,640
-4.6%
0.01%
+50.0%
Q4 2014$26,727,000
-6.8%
18,560,450
-1.0%
0.01%0.0%
Q3 2014$28,674,000
-56.2%
18,741,050
-2.9%
0.01%
-57.1%
Q2 2014$65,411,000
-4.5%
19,295,340
-0.3%
0.01%
-6.7%
Q1 2014$68,522,000
-66.7%
19,356,410
-42.4%
0.02%
-37.5%
Q4 2013$206,070,000
+142.3%
33,616,760
+130.0%
0.02%
+14.3%
Q3 2013$85,059,000
-39.1%
14,614,960
-52.5%
0.02%
+10.5%
Q2 2013$139,642,00030,758,2480.02%
Other shareholders
EXELIXIS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 15,001,073$199,507,00056.91%
Sargent Investment Group, LLC 1,032,560$18,193,0003.40%
Bellevue Group AG 3,930,700$69,259,0001.10%
CAPITAL MANAGEMENT CORP /VA 231,880$4,086,0001.04%
Orbimed Advisors 3,753,700$66,140,0000.94%
TEALWOOD ASSET MANAGEMENT INC 121,848$2,147,0000.90%
FARALLON CAPITAL MANAGEMENT LLC 7,500,000$132,150,0000.89%
Chicago Capital, LLC 806,113$14,204,0000.87%
Penn Capital Management Company, LLC 456,587$8,045,0000.84%
AJO, LP 7,636,882$134,561,0000.80%
View complete list of EXELIXIS INC shareholders